s6y
Company name or ticker
Search
Feener Edward P.
4
KalVista Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
Filed
Monday, August 21, 2023
Period
Aug 17, 2023
Accession number
0001209191-23-046823
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header